SARS-CoV-2: Reinfection after 18 Months of a Previous Case with Multiple Negative Nasopharyngeal Swab Tests and Positive Fecal Molecular Test
Abstract
:1. Introduction
2. A Brief Description of the Case
3. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lin, L.; Jiang, X.; Zhang, Z.; Huang, S.; Zhang, Z.; Fang, Z.; Gu, Z.; Gao, L.; Shi, H.; Mai, L.; et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020, 69, 997–1001. [Google Scholar] [CrossRef] [PubMed]
- Guo, M.; Tao, W.; Flavel, R.A.; Zhu, S. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 269–283. [Google Scholar] [CrossRef] [PubMed]
- Xiao, F.; Tang, M.; Zheng, X.; Liu, Y.; Li, X.; Shan, H. Evidence for Gastrointestinal Infection of SARS-CoV-2′. Gastroenterology 2020, 158, 1831–1833. [Google Scholar] [CrossRef] [PubMed]
- Zhou, J.; Li, C.; Liu, X.; Chiu, M.C.; Zhao, X.; Wang, D.; Wei, Y.; Lee, A.; Zhang, A.J.; Chu, H.; et al. Infection of bat and human intestinal organoids by SARS-CoV-2. Nat. Med. 2020, 26, 1077–1083. [Google Scholar] [CrossRef]
- Kampf, G.; Brüggemann, Y.; Kaba, H.E.J.; Steinmann, J.; Pfaender, S.; Scheithauer, S.; Steinmann, E. Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2. J. Hosp. Infect. 2020, 106, 678–697. [Google Scholar] [CrossRef]
- Han, M.S.; Seong, M.W.; Kim, N.; Shin, S.; Im Cho, S.; Park, H.; Kim, T.S.; Park, S.S.; Choi, E.H. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea. Emerg. Infect. Dis. 2020, 26, 2497–2499. [Google Scholar] [CrossRef]
- Han, D.; Fang, Q.; Wang, X. SARS-CoV-2 was found in the bile juice from a patient with severe COVID-19. J. Med. Virol. 2021, 93, 102–104. [Google Scholar] [CrossRef]
- Mukhra, R.; Krishan, K.; Kanchan, T. Possible modes of transmission of Novel coronavirus SARS-CoV-2: A review. Acta Biomed. 2020, 91, e2020036. [Google Scholar] [CrossRef]
- Young, B.E.; Ong, S.W.X.; Kalimuddin, S.; Low, J.G.; Tan, S.Y.; Loh, J.; Ng, O.-T.; Marimuthu, K.; Ang, L.W.; Mak, T.M.; et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA 2020, 323, 1488–1494. [Google Scholar] [CrossRef] [Green Version]
- Ong, S.W.X.; Tan, Y.K.; Chia, P.Y.; Air, S.E. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA 2020, 323, 1610–1612. [Google Scholar] [CrossRef] [Green Version]
- Weber, D.J.; Rutala, W.A.; Fischer, W.A.; Kanamori, H.; Sickbert-Bennett, E.E. Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9). Am. J. Infect. Control. 2016, 44, e91–e100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Amirian, E.S. Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health. Int. J. Infect. Dis. 2020, 95, 363–370. [Google Scholar] [CrossRef] [PubMed]
- Pedersen, R.M.; Tornby, D.S.; Bang, L.L.; Madsen, L.W.; Skov, M.N.; Sydenham, T.V.; Steinke, K.; Jensen, T.G.; Johansen, I.S.; Andersen, T.E.; et al. Rectally shed SARS-CoV-2 in COVID-19 inpatients is consistently lower than respiratory shedding and lacks infectivity. Clin. Microbiol. Infect. 2022, 28, 304.e1–304.e3. [Google Scholar] [CrossRef] [PubMed]
- Bonanno Ferraro, G.; Veneri, C.; Mancini, P.; Iaconelli, M.; Suffredini, E.; Bonadonna, L.; Lucentini, L.; Bowo-Ngandji, A.; Kengne-Nde, C.; Mbaga, D.S.; et al. A State-of-the-Art Scoping Review on SARS-CoV-2 in Sewage Focusing on the Potential of Wastewater Surveillance for the Monitoring of the COVID-19 Pandemic. Food Environ. Virol. 2021, 1–40. [Google Scholar] [CrossRef]
- Wu, W.; Shi, D.; Zhu, X.; Xie, J.; Xu, X.; Chen, Y.; Wu, J.; Li, L. Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces. Front. Cell. Infect. Microbiol. 2022, 12, 853212. [Google Scholar] [CrossRef] [PubMed]
- Guo, Y.; Wang, B.; Gao, H.; Gao, L.; Hua, R.; Xu, J.-D. ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology’. Front. Mol. Biosci. 2021, 8, 708336. [Google Scholar] [CrossRef]
- Suárez-Fariñas, M.; Tokuyama, M.; Wei, G.; Huang, R.; Livanos, A.; Jha, D.; Levescot, A.; Irizar, H.; Kosoy, R.; Cording, S.; et al. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially overlaps with the pathogenesis of SARS-CoV-2–related disease. Gastroenterology 2021, 160, 287–301. [Google Scholar] [CrossRef]
- Dong, M.; Zhang, J.; Ma, X.; Tan, J.; Chen, L.; Liu, S.; Xin, Y.; Zhuang, L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed. Pharmacother. 2020, 131, 110678. [Google Scholar] [CrossRef]
- Dipasquale, V.; Passanisi, S.; Cucinotta, U.; Cascio, A.; Romano, C. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital. J. Pediatr. 2021, 47, 71. [Google Scholar] [CrossRef]
- Al-Beltagi, M.; Saeed, N.K.; Bediwy, A.S.; El-Sawaf, Y. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications. World J. Gastroenterol. 2021, 27, 1716–1727. [Google Scholar] [CrossRef]
- Livanos, A.E.; Jha, D.; Cossarini, F.; Gonzalez-Reiche, A.S.; Tokuyama, M.; Aydillo, T.; Parigi, T.L.; Ladinsky, M.S.; Ramos, I.; Dunleavy, K.; et al. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients with Gastrointestinal Symptoms. Gastroenterology 2021, 160, 2435–2450.e34. [Google Scholar] [CrossRef] [PubMed]
- Hansen, T.; Titze, U.; Kulamadayil-Heidenreich, N.S.A.; Glombitza, S.; Tebbe, J.J.; Röcken, C.; Schulz, B.; Weise, M.; Wilkens, L. First case of postmortem study in a patient vaccinated against SARS-CoV-2. Int. J. Infect. Dis 2021, 107, 172–175. [Google Scholar] [CrossRef] [PubMed]
- Dhumal, S.; Patil, A.; More, A.; Kamtalwar, S.; Joshi, A.; Gokarn, A.; Mirgh, S.; Thatikonda, P.; Bhat, P.; Murthy, V.; et al. SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study. Int. J. Infect. Dis. 2022, 118, 95–103. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.K.; Lee, B.; Choi, Y.Y.; Um, J.; Lee, K.S.; Sung, H.K.; Kim, Y.; Park, J.-S.; Lee, M.; Jang, H.-C.; et al. Clinical Characteristics of 40 Patients Infected with the SARS-CoV-2 Omicron Variant in Korea. J. Korean Med. Sci. 2022, 37, e31. [Google Scholar] [CrossRef] [PubMed]
- Peiris, M.; Cheng, S.; Mok, C.K.P.; Leung, Y.; Ng, S.; Chan, K.; Ko, F.; Yiu, K.; Lam, B.; Lau, E.; et al. Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines. Res. Sq. 2022; preprint. [Google Scholar] [CrossRef]
- Rahman, S.; Rahman, M.M.; Miah, M.; Begum, M.N.; Sarmin, M.; Mahfuz, M.; Hossain, M.E.; Rahman, M.Z.; Chisti, M.J.; Ahmed, T.; et al. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci. Rep. 2022, 12, 1438. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Kaperak, C.; Sato, T.; Sakuraba, A. COVID-19 reinfection: A rapid systematic review of case reports and case series. J. Investig. Med. 2021, 69, 1253–1255. [Google Scholar] [CrossRef]
- Brogna, B.; Bignardi, E.; Brogna, C.; Capasso, C.; Gagliardi, G.; Martino, A.; Musto, L.A. COVID-19 Pneumonia in Vaccinated Population: A Six Clinical and Radiological Case Series. Medicina 2021, 57, 891. [Google Scholar] [CrossRef]
- Brogna, B.; Brogna, C.; Petrillo, M.; Conte, A.M.; Benincasa, G.; Montano, L.; Piscopo, M. Detection in Fecal Sample from a Patient with Typical Findings of COVID-19 Pneumonia on CT but Negative to Multiple SARS-CoV-2 RT-PCR Tests on Oropharyngeal and Nasopharyngeal Swab Samples. Medicina 2021, 57, 290. [Google Scholar] [CrossRef]
- Petrillo, M.; Brogna, C.; Cristoni, S.; Querci, M.; Piazza, O.; Van den Eede, G. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology. F1000Research 2021, 10, 370. [Google Scholar] [CrossRef]
- Brogna, C.; Cristoni, S.; Petrillo, M.; Querci, M.; Piazza, O.; Van den Eede, G. Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients. F1000Research 2021, 10, 550. [Google Scholar] [CrossRef] [PubMed]
- Petrillo, M.; Querci, M.; Brogna, C.; Ponti, J.; Cristoni, S.; Markov, P.V.; Valsesia, A.; Leoni, G.; Benedetti, A.; Wiss, T.; et al. Evidence of SARS-CoV-2 bacteriophage potential in human gut microbiota. F1000Research 2022, 11, 292. [Google Scholar] [CrossRef]
- Isidoro, C.; Chiung-Fang Chang, A.; Sheen, L.-Y. Natural products as a source of novel drugs for treating SARS-CoV2 infection. J. Tradit. Complement. Med. 2022, 12, 1–5. [Google Scholar] [CrossRef]
- Vitale, J.; Mumoli, N.; Clerici, P.; De Paschale, M.; Evangelista, I.; Cei, M.; Mazzone, A. Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy. JAMA Intern. Med. 2021, 181, 1407–1408. [Google Scholar] [CrossRef] [PubMed]
- West, J.; Everden, S.; Nikitas, N. A case of COVID-19 reinfection in the UK. Clin. Med. Lond. Engl. 2021, 21, e52–e53. [Google Scholar] [CrossRef]
- Habadi, M.; Balla Abdalla, T.H.; Hamza, N.; Al-Gedeei, A. COVID-19 Reinfection. Cureus 2021, 13, e12730. [Google Scholar] [CrossRef]
- Mao, Y.; Wang, W.; Ma, J.; Wu, S.; Sun, F. Reinfection rates among patients previously infected by SARS-CoV-2: Systematic review and meta-analysis. Chin. Med. J. 2021, 135, 145–152. [Google Scholar] [CrossRef]
- Tsang, N.N.Y.; So, H.C.; Ng, K.Y.; Cowling, B.J.; Leung, G.M.; Ip, D.K.M. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: A systematic review and meta-analysis. Lancet Infect. Dis. 2021, 21, 1233–1245. [Google Scholar] [CrossRef]
- Clerici, B.; Muscatello, A.; Bai, F.; Pavanello, D.; Orlandi, M.; Marchetti, G.; Castelli, V.; Casazza, G.; Costantino, G.; Podda, G.M. Sensitivity of SARS-CoV-2 Detection with Nasopharyngeal Swabs. Front. Public Health 2021, 8, 593491. [Google Scholar] [CrossRef]
- Butler-Laporte, G.; Lawandi, A.; Schiller, I.; Yao, M.; Dendukuri, N.; McDonald, E.G.; Lee, T.C. Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2021, 181, 353–360. [Google Scholar] [CrossRef]
- Tahamtan, A.; Ardebili, A. Real-time RT-PCR in COVID-19 detection: Issues affecting the results. Expert Rev. Mol. Diagn. 2020, 20, 453–454. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Abdullah, M.; Sudrajat, D.G.; Muzellina, V.N.; Kurniawan, J.; Rizka, A.; Utari, A.P.; Pribadi, R.R.; Idrus, M.F.; Yusra, Y.; Meilany, S.; et al. The value of anal swab RT-PCR for COVID-19 diagnosis in adult Indonesian patients. BMJ Open Gastroenterol. 2021, 8, e000590. [Google Scholar] [CrossRef] [PubMed]
- Zheng, S.; Fan, J.; Yu, F.; Feng, B.; Lou, B.; Zou, Q.; Xie, G.; Lin, S.; Wang, R.; Yang, X.; et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: Retrospective cohort study. BMJ 2020, 369, m1443. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheung, K.S.; Hung, I.F.; Chan, P.P.; Lung, K.C.; Tso, E.; Liu, R.; Ng, Y.Y.; Chu, M.Y.; Chung, T.W.H.; Tam, A.R.; et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology 2020, 159, 81–95. [Google Scholar] [CrossRef]
- Wu, Y.; Guo, C.; Tang, L.; Hong, Z.; Zhou, J.; Dong, X.; Yin, H.; Xiao, Q.; Tang, Y.; Qu, X.; et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020, 5, 434–435. [Google Scholar] [CrossRef]
- Matuchansky, C. Mucosal immunity to SARS-CoV-2: A clinically relevant key to deciphering natural and vaccine-induced defences. Clin. Microbiol. Infect. 2021, 27, 1724–1726. [Google Scholar] [CrossRef]
- Sabin, A.B. Polio vaccine. Rev. Medica Cordoba 1956, 44, 194–196. [Google Scholar]
- Lapuente, D.; Fuchs, J.; Willar, J.; Vieira Antão, A.; Eberlein, V.; Uhlig, N.; Issmail, L.; Schmidt, A.; Oltmanns, F.; Peter, A.S.; et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat. Commun. 2021, 12, 6871. [Google Scholar] [CrossRef]
- Mak, T.W.; Saunders, M.E. The Immune Response: Basic and Clinical Principles; Elsevier: Amsterdam, The Netherlands; Academic: Amsterdam, The Netherlands, 2006; Available online: http://www.dawsonera.com/abstract/9780080534480 (accessed on 1 April 2022).
- Alu, A.; Chen, L.; Lei, H.; Wei, Y.; Tian, X.; Wei, X. Intranasal COVID-19 vaccines: From bench to bed. EBioMedicine 2022, 76, 103841. [Google Scholar] [CrossRef]
- Mudgal, R.; Nehul, S.; Tomar, S. Prospects for mucosal vaccine: Shutting the door on SARS-CoV-2. Hum. Vaccin Immunother. 2020, 16, 2921–2931. [Google Scholar] [CrossRef]
Laboratory Parameters | SU | Patient’s Value | Normal |
---|---|---|---|
Hemoglobin | mg/dL | 16.2 | 13.0–17.5 |
Mean cell volume | fL | 94.2 | 80.0–98.0 |
Platelets count | X1000/µL | 167 | 140.00–450.00 |
White blood count | X1000/µL | 6.29 | 4.00–11.0 |
Neutrophils | % | 70.8 | 40.0–75.0 |
Lymphocytes | % | 21.4 | 20.0–50.0 |
Monocytes | % | 6.8 | 0.0–11.0 |
Eosinophils | % | 0.8 | 0.0–0.7 |
Basophiles | % | 0.2 | 0.0–0.2 |
Aspartate transaminases | U/L | 25 | <37 |
Alanine transaminases | U/L | 30 | <41 |
Glycemia | mg/dL | 94 | 60–110 |
Creatinine | mg/dL | 1.01 | 0.7–1.3 |
Cholinesterase | U/L | 8850 | 4850–12,000 |
C Reactive Protein | mg/dL | 0.22 | <0.5 |
D-Dimer | mg/dL | 193.4 ng/mL | <500 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Brogna, C.; Brogna, B.; Bisaccia, D.R.; Giuliano, M.; Montano, L.; Cristoni, S.; Petrillo, M.; Piscopo, M. SARS-CoV-2: Reinfection after 18 Months of a Previous Case with Multiple Negative Nasopharyngeal Swab Tests and Positive Fecal Molecular Test. Medicina 2022, 58, 642. https://doi.org/10.3390/medicina58050642
Brogna C, Brogna B, Bisaccia DR, Giuliano M, Montano L, Cristoni S, Petrillo M, Piscopo M. SARS-CoV-2: Reinfection after 18 Months of a Previous Case with Multiple Negative Nasopharyngeal Swab Tests and Positive Fecal Molecular Test. Medicina. 2022; 58(5):642. https://doi.org/10.3390/medicina58050642
Chicago/Turabian StyleBrogna, Carlo, Barbara Brogna, Domenico Rocco Bisaccia, Marino Giuliano, Luigi Montano, Simone Cristoni, Mauro Petrillo, and Marina Piscopo. 2022. "SARS-CoV-2: Reinfection after 18 Months of a Previous Case with Multiple Negative Nasopharyngeal Swab Tests and Positive Fecal Molecular Test" Medicina 58, no. 5: 642. https://doi.org/10.3390/medicina58050642